News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Yi Lin: Bispecific antibodies therapies in multiple myeloma
Yi Lin/x
Apr 14, 2025, 09:30

Yi Lin: Bispecific antibodies therapies in multiple myeloma

Yi Lin, Professor at Mayo Clinic Comprehensive Cancer Center, shared a post on X:

“Now delving into bispecific antibodies therapies in multiple myeloma at iwCART25.

We have 3 antigen targets, dual & triple targets in clinic & trials. How best to optimize their use?

Rakesh Popat starts with Cevostamab data.”
Bispecific antibodies therapies cancer Cevostamab fight against cancer Global fight against cancer iwCART25 Mayo Clinic Comprehensive Cancer Center multiple myeloma OncoDaily Oncology Rakesh Popat Yi Lin
Special Coverage
Science
Jun 16, 2025, 17:06
Carmen Criscitiello Highlights Strategies to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer
Career
Jun 16, 2025, 16:15
Congratulations to the 2025 Young Investigator Award Winners - SIOP
Blog
Jun 16, 2025, 16:02
Naveen Pemmaraju Highlighted Musa Yilmaz's EHA 2025 Presentation on DEC/VEN/QUIZ in FLT3-ITD AML
Science
Jun 16, 2025, 16:01
Myeloma Paper of the Day, June 16th, suggested by Robert Orlowski
Blog
Jun 16, 2025, 16:01
This Men’s Health Week, Let’s Keep It Simple: Small Choices Add Up to Big Results - NFCR
Blog
Jun 16, 2025, 16:00
Join Pillar 1 of the National Cancer Control Strategy to Discuss Cancer Prevention and Early Detection - National Cancer Institute of Kenya
Blog
Jun 16, 2025, 15:44
Van Morris: Congrats to Kelsey Pan on Her MD Anderson Cancer Center Fellowship Graduation
Blog
Jun 16, 2025, 15:19
Yu-Hung Wang: With Great Pleasure to Meet Prof Naveen Pemmaraju at EHA2025
Blog
Jun 16, 2025, 12:20
City of Hope Orange County Shares Father’s Day Story of Blood Cancer Survivor and Son’s Lifesaving Donation
Oncolibrary
Jun 16, 2025, 12:18
EHA 2025 Highlights: POLARGO Trial Shows OS Benefit with Pola-R-GemOx in Transplant-Ineligible R/R DLBCL
Blog
Jun 16, 2025, 11:54
Vincent Rajkumar Shares Data Showing China Leads in Oncology Trial Initiations and New Cancer Drug Launches
Blog
Jun 16, 2025, 11:44
Daniel Auclair Highlights GMMG-CONCEPT Study Presentation by Lisa Leypoldt at EHA 2025